MIAMI--(BUSINESS WIRE)--April 6, 2006--DOR BioPharma, Inc. (“DOR” or the “Company”) (AMEX:DOR - News) announced that it has entered into definitive agreements for the sale of securities in a private placement to institutional investors with gross proceeds to the Company of approximately $3.65 million.
